The North America infectious disease in vitro diagnostics (IVD) market is witnessing robust growth driven by increasing prevalence of infectious diseases, rising demand for early and accurate diagnosis, and continuous advancements in diagnostic technologies. The infectious disease in vitro diagnostics market size is projected to reach US$ 76.71 billion by 2031 from US$ 45.69 billion in 2024....